Title:
A Phase 3b Randomized Clinical Trial of Nivolumab alone, Nivolumab in Combination with Ipilimumab, or an Investigators Choice Chemotherapy in Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Metastatic Colorectal Cancer
Phase:
III
Contact:
Julia Weck / Study Nurse
Email-Address:
Julia.Weck@med.uni-heidelberg.de
Clinical Investigator:
PD Dr. Georg Martin Haag
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT04008030
EudraCT-Number:
(siehe EU klinisches Studienregister)
2018-000040-26